Search Results

There are 11842 results for: content related to: Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer

  1. You have free access to this content
    Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer

    Cancer

    Volume 120, Issue 5, 1 March 2014, Pages: 624–632, Julie E. Bauman and Robert L. Ferris

    Version of Record online : 12 NOV 2013, DOI: 10.1002/cncr.28380

  2. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  3. You have free access to this content
    A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies

    Cancer

    Volume 121, Issue 10, May 15, 2015, Pages: 1645–1653, John F. Deeken, Hongkun Wang, Deepa Subramaniam, Aiwu Ruth He, Jimmy Hwang, John L. Marshall, Christina E. Urso, Yiru Wang, Corinne Ramos, Kenneth Steadman and Michael J. Pishvaian

    Version of Record online : 29 JAN 2015, DOI: 10.1002/cncr.29224

  4. You have full text access to this OnlineOpen article
    A systematic review of treatment guidelines for metastatic colorectal cancer

    Colorectal Disease

    Volume 14, Issue 2, February 2012, Pages: e31–e47, M. S. Edwards, S. D. Chadda, Z. Zhao, B. L. Barber and D. P. Sykes

    Version of Record online : 10 JAN 2012, DOI: 10.1111/j.1463-1318.2011.02765.x

  5. Using the galactose-α-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab

    Cancer

    Volume 122, Issue 11, June 1, 2016, Pages: 1697–1701, Jared Weiss, Juneko Grilley Olson, Allison Mary Deal, Bhishamjit Chera, Mark Weissler, Barbara A. Murphy, David Neil Hayes and Jill Gilbert

    Version of Record online : 15 MAR 2016, DOI: 10.1002/cncr.29978

  6. You have free access to this content
    Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases

    Cancer

    Volume 119, Issue 19, 1 October 2013, Pages: 3429–3435, Francesco Leone, Salvatore Artale, Donatella Marino, Celeste Cagnazzo, Stefano Cascinu, Carmine Pinto, Giuseppe Fornarini, Marco Tampellini, Francesca Di Fabio, Andrea Sartore-Bianchi, Luciano De Carlis, Raffaele Pugliese, Lorenzo Capussotti, Luisa Gioeni, Salvatore Siena and Massimo Aglietta

    Version of Record online : 18 JUL 2013, DOI: 10.1002/cncr.28223

  7. You have free access to this content
    Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany

    International Journal of Cancer

    Volume 131, Issue 2, 15 July 2012, Pages: 438–445, Arthi Vijayaraghavan, Molly B. Efrusy, Burkhard Göke, Thomas Kirchner, Christopher C. Santas and Richard M. Goldberg

    Version of Record online : 3 JAN 2012, DOI: 10.1002/ijc.26400

  8. You have free access to this content
    Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer

    Cancer

    Volume 120, Issue 1, 1 January 2014, Pages: 77–85, Christine A. Ciunci, Rodolfo F. Perini, Anjali N. Avadhani, Hyunseon C. Kang, Weijing Sun, Maryann Redlinger, Kathleen Harlacker, Keith T. Flaherty, Bruce J. Giantonio, Mark A. Rosen, Chaitanya R. Divgi, Hee Kwon Song, Sarah Englander, Andrea Troxel, Mitchell Schnall and Peter J. O'Dwyer

    Version of Record online : 24 SEP 2013, DOI: 10.1002/cncr.28294

  9. You have free access to this content
    Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

    Cancer

    Volume 120, Issue 24, December 15, 2014, Pages: 3940–3951, Nabil F. Saba, Selwyn J. Hurwitz, Kelly Magliocca, Sungjin Kim, Taofeek K. Owonikoko, Donald Harvey, Suresh S. Ramalingam, Zhengjia Chen, Jackie Rogerio, Jennifer Mendel, Scott A. Kono, Colleen Lewis, Amy Y. Chen, Kristin Higgins, Mark El-Deiry, Trad Wadsworth, Jonathan J. Beitler, Dong M. Shin, Shi-Yong Sun and Fadlo R. Khuri

    Version of Record online : 7 AUG 2014, DOI: 10.1002/cncr.28965

  10. You have free access to this content
    Review article: panitumumab - a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 3, August 2008, Pages: 269–281, M. PEETERS, J. BALFOUR and D. ARNOLD

    Version of Record online : 4 JUL 2008, DOI: 10.1111/j.1365-2036.2008.03717.x

  11. Second-line systemic therapy for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    Simone Mocellin, Zora Baretta, Marta Roqué i Figuls, Ivan Solà, Marta Martin-Richard, Sara Hallum and Xavier Bonfill Cosp

    Published Online : 27 JAN 2017, DOI: 10.1002/14651858.CD006875.pub3

  12. You have free access to this content
    Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non–small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508)

    Cancer

    Volume 121, Issue 13, July 1, 2015, Pages: 2253–2261, Nasser H. Hanna, Suzanne E. Dahlberg, Jill M. Kolesar, Charu Aggarwal, Fred R. Hirsch, Suresh S. Ramalingam and Joan H. Schiller

    Version of Record online : 4 MAR 2015, DOI: 10.1002/cncr.29308

  13. The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors

    Journal of Surgical Oncology

    Volume 102, Issue 8, 15 December 2010, Pages: 891–897, Harold J. Wanebo and David Berz

    Version of Record online : 16 DEC 2010, DOI: 10.1002/jso.21691

  14. You have free access to this content
    Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date

    Cancer

    Volume 121, Issue 4, February 15, 2015, Pages: 502–516, Jayson I. L. Bastien, Katharine A. McNeill and Howard A. Fine

    Version of Record online : 23 SEP 2014, DOI: 10.1002/cncr.28968

  15. Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: The role of anti-VEGF and anti-EGFR antibodies

    Journal of Surgical Oncology

    Volume 102, Issue 8, 15 December 2010, Pages: 937–945, Ravit Geva, Hans Prenen, Baki Topal, Raymond Aerts, Jaarke Vannoote and Eric Van Cutsem

    Version of Record online : 16 DEC 2010, DOI: 10.1002/jso.21760

  16. You have free access to this content
    Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer

    Cancer

    Volume 119, Issue 24, 15 December 2013, Pages: 4223–4230, Christopher R. Garrett, Tanios S. Bekaii-Saab, Theresa Ryan, George A. Fisher, Sally Clive, Petr Kavan, Einat Shacham-Shmueli, Aby Buchbinder and Richard M. Goldberg

    Version of Record online : 16 SEP 2013, DOI: 10.1002/cncr.28358

  17. Epidermal Growth Factor Receptor Monoclonal Antibodies for the Treatment of Metastatic Colorectal Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 6, June 2008, Pages: 742–754, Gary W. Jean and Sachin R. Shah

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.6.742

  18. You have free access to this content
    Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

    Cancer

    Volume 122, Issue 4, February 15, 2016, Pages: 574–581, Francesco Leone, Donatella Marino, Stefano Cereda, Roberto Filippi, Carmen Belli, Rosella Spadi, Guglielmo Nasti, Massimo Montano, Alessio Amatu, Giuseppe Aprile, Celeste Cagnazzo, Gianpiero Fasola, Salvatore Siena, Libero Ciuffreda, Michele Reni and Massimo Aglietta

    Version of Record online : 5 NOV 2015, DOI: 10.1002/cncr.29778

  19. You have free access to this content
    What is the best treatment for patients with human papillomavirus–positive and –negative oropharyngeal cancer?

    Cancer

    Volume 120, Issue 10, 15 May 2014, Pages: 1462–1470, Damien Urban, June Corry and Danny Rischin

    Version of Record online : 27 FEB 2014, DOI: 10.1002/cncr.28595

  20. You have free access to this content
    Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

    Cancer

    Volume 119, Issue 16, 15 August 2013, Pages: 2973–2980, Luis O. Olivatto, Fernando M. Vieira, Bruno V. Pereira, Ana P. Victorino, Marcos Bezerra, Carlos M. Araujo, Felipe Erlich, Lilian Faroni, Leonaldson Castro, Edward C. Lusis, Alessandra Marins and Carlos Gil Ferreira

    Version of Record online : 14 MAY 2013, DOI: 10.1002/cncr.28045